However, compared with other tissues, PSMA expression significantly increases in prostate cancer (PCa), where it is localized at the luminal surface of the prostatic ducts and presents a large extracellular ligand-binding domain [6,7,8]. This evidence concerns the gene FOLH1 and prostate cancer.